brfrancis/CompetingRisksAnalysisGW: Release Candidate 1

Release Candidate 1 with full functionality!

The CRAG software provides a novel tool for the analysis of GWAS with TTE outcomes with competing risks. As CRAG is compatible with high performance parallel computing clusters, thereby allowing efficient and effective analysis of large scale GWAS datasets, without incurring memory issues. The main use of CRAG is expected to be in pharmacogenetic studies to identify genetic biomarkers of patient response to treatment, with the ultimate goal of personalising therapeutic intervention for an array of diseases.